Mesoblast (02415.HK) has released its interim results, with a net profit of 13.239 million yuan, a year-on-year increase of 5238.3%.

Zh tng cijng APP xn, mi s jinkng (02415.HK) fb 2025 nin zhngq yj, shuy 1.25 y yun (rn mn b, xi tng), tngb zngzhng 13.2%; jngl 1323.9 wn yun, tngb zngzhng 5238.3%; mi g jbn yngl 2.45 fn, n pi zhngq gx mi g 1.1 gng xin. According to the Wise News App, Mason Health (02415.HK) has released its mid-term performance for 2025, with revenue of 125 million yuan (RMB, the same below), a year-on-year increase of 13.2%; net profit of 13.239 million yuan, a year-on-year increase of 5238.3%; basic earnings per share of 2.45 cents, with a proposed mid-term dividend of 1.1 Hong Kong cents per share.